grant

HIV immune evasion and escape through T cell virological synapses

Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAILocation NEW YORK, UNITED STATESPosted 14 Sept 2020Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY2026AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAntibodiesAntibody ResponseAntigenic DeterminantsAssayBar CodesBindingBinding DeterminantsBioassayBiochemicalBiological AssayBiotinCell AdhesionCell BodyCell Communication and SignalingCell Culture TechniquesCell FunctionCell PhysiologyCell ProcessCell SignalingCell surfaceCellsCellular AdhesionCellular FunctionCellular PhysiologyCellular ProcessCellular biologyChimera ProteinChimeric ProteinsCombined Modality TherapyDataDetectionEndocytosisEndosomesEnv trimerEpitopesEvolutionFaceFusion ProteinGenesGlycoproteinsHIVHIV EnvHIV disease transmissionHIV envelopeHIV envelope proteinHIV glycoprotein EnvHIV infection spreadHIV infection transmissionHIV spreadHIV transmissionHIV viral transmissionHIV-1HIV-1 EnvHIV-1 envelopeHIV-1 glycoprotein EnvHIV-1 spreadHIV-1 transmissionHIV-1 virus transmissionHIV-IHIV/AIDS transmissionHIV1HeterogeneityHuman Immunodeficiency Virus Type 1Human Immunodeficiency Virus Type 1 transmissionHuman Immunodeficiency Virus-1Human Immunodeficiency VirusesHuman immunodeficiency virus 1ImageImmuneImmune EvasionImmune responseImmune systemImmunesIn VitroInfectionIntracellular Communication and SignalingKnowledgeLAV-HTLV-IIILabelLearningLong-term infectionLymphadenopathy-Associated VirusLymphatic TissueLymphoid TissueMasksMeasuresMediatingMembrane FusionMetabolic GlycosylationModelingMolecular ConfigurationMolecular ConformationMolecular InteractionMolecular StereochemistryMultimodal TherapyMultimodal TreatmentMutatePathway interactionsPatternPeptidesPlayProcessReceptor ProteinReceptosomesRecyclingRoleShapesSignal TransductionSignal Transduction SystemsSignalingSubcellular ProcessSurfaceT-CellsT-LymphocyteTestingTherapeutic antibodiesTransmissionViralViral DiseasesViral Gene ProductsViral Gene ProteinsViral ProteinsVirionVirusVirus DiseasesVirus ParticleVirus-HIVVitamin HWorkadhesion receptorbarcodebiological signal transductioncell biologycell culturecell cultureschronic infectioncoenzyme Rcombination therapycombined modality treatmentcombined treatmentconformationconformationalconformational stateconformationallyconformationsfacesfacialgene manipulationgenetic manipulationgenetically manipulategenetically perturbglycosylationgp160host responsehuman immunodeficiency virus transmissionhumanized micehumanized mouseimagingimmune evasiveimmune system responseimmunoresponseimprovedin vivoinhibitormouse modelmulti-modal therapymulti-modal treatmentmurine modelmutantneutralizing antibodynew vaccinesnext generation vaccinesnovel vaccinespathwaypersistent infectionpressureratiometricreceptorrecruitresponsescRNA sequencingscRNA-seqsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolespread of human immunodeficiency virussynapse formationsynaptogenesissynergismthymus derived lymphocytetraffickingtransmission processvaccine antibodiesvaccine induced antibodiesvaccine-induced antibodiesviral infectionvirological synapsevirus infectionvirus proteinvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
HIV-1 establishes a chronic infection that the immune system cannot spontaneously clear. The virus has a

remarkable capacity to evade immune responses and generates a high sequence diversity that tolerates

defective genes. We and others have found that viral dissemination takes place both in vitro and in vivo

through cell-cell contacts, called virological synapses (VS), which can help mask immune detection of infected

cells, and promote viral quasispecies diversity that enable escape. Our data indicate that HIV Env, the central

viral protein involved in VS formation and viral entry, is regulated during the process of cell-to-cell transmission

and assumes distinct conformations on the cell surface versus the virus particle. We examine how low

abundance, rapid turnover and heterogeneity of processing of Env at the cell surface contributes to diminished

antigenicity of infected cells as compared to abundant cell-free virus or shed glycoprotein. The studies

proposed here test a model whereby the sequence of Env trafficking--to the cell surface, to the recycling

endosome, and then to the virus particle--supports distinct antigenic states along this pathway. In the prior

study periods we have learned that during VS formation Env works as a cell adhesion receptor between the

infected and uninfected cell, prior to its role as viral membrane fusion protein. HIV exploits cell biology

including the polarized receptor recruitment and viral endocytosis into the target cell, to enhance cell-to-cell

transmission. The T cell VS is critical for viral spread in cell culture and functions in vivo in lymphoid tissues of

humanized mice. Most broadly neutralizing antibodies (bNAbs) are less potent at neutralizing cell-to-cell

infection than the same virus in a cell-free form. When tested against transmitted founder clones, bNAbs

frequently fail to inhibit 100% of cell-to-cell infection at maximum concentration, i.e. display reduced efficacy.

In the continuation of these studies, we will define the cellular mechanisms underlying the reduced potency

and efficacy of neutralizing antibodies against the VS. We will also test a model for how the multicopy

transmission of HIV through VS contributes to maintaining a diverse swarm of mutated sequences, or

quasispecies, that promotes immune escape. We hypothesize that cell-to-cell HIV-1 transmission is a pivotal

immune evasion and escape strategy that drives viral persistence.

Grant Number: 5R37AI148064-15
NIH Institute/Center: NIH

Principal Investigator: BENJAMIN CHEN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →